Guerra Advisors’s Quest Diagnostics DGX Stock Holding History

Guerra Advisors’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$1.14K	Buy	+6	New	+$1.06K	﹤0.01%	636

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Guerra Advisors's DGX Position: Q3 2025 in Review

Guerra Advisors opened a new position in Quest Diagnostics (DGX) in Q3 2025: 6 shares worth $1.14K. The stake represents ﹤0.01% of the portfolio and ranks #636 among its holdings.

1,006 funds tracked by Wall St. Rank hold DGX as of Q3 2025.

Guerra Advisors held 6 shares of Quest Diagnostics worth $1.14K as of Q3 2025.
Quest Diagnostics was a new Guerra Advisors position in Q3 2025.
Quest Diagnostics made up ﹤0.01% of Guerra Advisors's portfolio in Q3 2025, its #636 holding.
1,006 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2025.

Based on Guerra Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.